SLC16A3 and neoplasm: Indeed, MCT1/4 inhibition improved CD8+ T cell functionality in vitro, and the MCT4 inhibitor 7acc1 enhanced NK cell cytotoxicity and attenuated tumor growth in the murine 4T1 TNBC model (147).